← Back to headlines
Corcept Projects $900M–$1B Revenue for 2026
Corcept has provided its revenue guidance for 2026, projecting between $900 million and $1 billion, as the approval for its relacorilant oncology drug approaches.
25 Feb, 00:48 — 25 Feb, 00:48
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Finance Ministry: Securities Commission to finalise framework, licensing rules for cash trust schemes
41m ago
Kuching police: Man loses RM1.1m after being lured into bogus ‘FYC’ stock investment app
52m ago
South Korean Financial Watchdog Urges Foreign Firms to Invigorate Market
53m ago
OCBC Projects Stable to Rising Income for 2026
1h ago